Watch CBS News

What possible compounded semaglutide ban means

The FDA declared the shortage of Novo Nordisk's weight-loss drugs over, giving compounders until May to stop making alternatives. An industry group representing compounders is suing. Dr. Angela Fitch discusses what this means for patients.
Feb 27, 2025 (06:35)
Videos
View CBS News In
CBS News App Open
Chrome Safari Continue